Designed Antibodies as Weapons against Infectious Diseases Jan - PowerPoint PPT Presentation

Nov 01, 2023 •482 likes •663 views

Designed Antibodies as Weapons against Infectious Diseases Jan Terje Andersen Department of Biosciences - University of Oslo Department of Immunology - Oslo University Hospital Viruses 3 http://www.public-domain-image.com/free-imagesh

Designed Antibodies as Weapons against Infectious Diseases Jan Terje Andersen Department of Biosciences - University of Oslo Department of Immunology - Oslo University Hospital
Viruses 3 http://www.public-domain-image.com/free-imagesh ttp://phil.cdc.gov/phil/quicksearch.asp
Genetic material Protein coat Photo: Dan Higgins. ttp://phil.cdc.gov/phil/quicksearch.asp
The winter vomiting bug
The immune system
7
BUBBLE BOY DISEASE 8 Credit: Baylor College of Medicine Photo Archives
Antibiotics and anti-viral drugs
The Body’s Binding to intruder Foot Soldiers Binding to cells 10
Expanding use of therapeutic antibodies • The fastest growing class of bio-therapeutics • The global sale in 2014: >100 billion USD • Autoimmune diseases and cancer • Few against infectious diseases
12
Designed foot soldiers Site-specific Improved binding to modifications cell receptors
Killing of a virus in cell cultures 0% 50% 100% Natural antibody Designed antibodies
The soldiers are patrolling the blood
Superior lifespan of antibodies beyond that of natural antibodies Level in blood Designed antibodies Natural antibody Days after injection
• Patient compliance • Economy • Health system

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

affects the immune system? ARMY OF WHITE BLOOD CELLS ANTIBODIES ARE ARROW LIKE WEAPONS GERM

Did you know a food allergy affects the immune system? ARMY OF WHITE BLOOD CELLS ANTIBODIES ARE ARROW LIKE WEAPONS GERM Inside your body are things called white blood cells that fight germs and help us from becoming sick. These

500 views • 20 slides

Guideline on Biosimilar Monoclonal Antibodies Non-clinical issues A risk-based approach -

Guideline on Biosimilar Monoclonal Antibodies Non-clinical issues A risk-based approach - rationale and decision points Closed Workshop on biosimilar monoclonal antibodies and immunogenicity of monoclonal antibodies EMA, London, 24 th Oct 2011

1.36k views • 8 slides

Antibodies and Antigens Antibodies and Antigens Your body s natural defense s natural

Antibodies and Antigens Antibodies and Antigens Your body s natural defense s natural defense Your body system system Antibodies Antibodies The formal chemical name for antibodies The formal chemical name for antibodies is

131 views • 12 slides

Bioventix Presentation: October 2019 Bioventix & antibodies for blood testing Bioventix

1 Bioventix Presentation: October 2019 Bioventix & antibodies for blood testing Bioventix portfolio of antibodies and their advantages 2018/19 final results and comment Research and pipeline development Business continuity

628 views • 15 slides

Bioventix Presentation: April 2019 Bioventix & antibodies for blood testing Bioventix

1 Bioventix Presentation: April 2019 Bioventix & antibodies for blood testing Bioventix portfolio of antibodies and their advantages 2018/19 interim results and comment Pipeline development Business continuity

351 views • 14 slides

Bioventix Presentation: March 2018 Bioventix & antibodies for blood testing Bioventix

1 Bioventix Presentation: March 2018 Bioventix & antibodies for blood testing Bioventix portfolio of antibodies and their advantages 2017/18 interim results and analysis Business continuity Shareholders & the Board

416 views • 15 slides

Bioventix Presentation: October 2018 Bioventix & antibodies for blood testing Bioventix

1 Bioventix Presentation: October 2018 Bioventix & antibodies for blood testing Bioventix portfolio of antibodies and their advantages 2017/18 results and analysis Pipeline development Business continuity Shareholders

173 views • 15 slides

Bioventix Presentation: October 2017 Bioventix & antibodies for blood testing Bioventix

1 Bioventix Presentation: October 2017 Bioventix & antibodies for blood testing Bioventix portfolio of antibodies and their advantages 2016/17 results and analysis Business continuity Shareholders & the Board

392 views • 15 slides

Nuclear Weapons Nuclear Weapons They produce incredible temperatures They produce incredible

Nuclear Weapons 2 Observations about Nuclear Weapons 1 Observations about Nuclear Weapons Nuclear Weapons They release enormous amounts of energy They release enormous amounts of energy Nuclear Weapons Nuclear Weapons They produce

393 views • 3 slides

Bioventix Presentation: June 2016 Blood testing and antibodies Bioventix portfolio of

1 Bioventix Presentation: June 2016 Blood testing and antibodies Bioventix portfolio of antibodies and their advantages Financial data Business continuity Team and Research activities Shareholders Outlook 2 Blood Testing and

327 views • 17 slides

Autonomous Weapons Systems and the Obligation to Exercise Discretion Presentation at the 2016

1 Autonomous Weapons Systems and the Obligation to Exercise Discretion Presentation at the 2016 Meeting of Experts on Lethal Autonomous Weapons Systems, Convention on Certain Conventional Weapons (CCW), Geneva, 14 April 2016 Eliav Lieblich 1

259 views • 9 slides

Nuclear Weapons 101 Nuclear Smuggling p. Nuclear Weapons 101 Fissile materials ( 235 U , 233

Nuclear Weapons 101 Nuclear Smuggling p. Nuclear Weapons 101 Fissile materials ( 235 U , 233 U , 239 Pu ) are used to make weapons of devastating power. Nuclear Smuggling p. Nuclear Weapons 101 Fissile materials ( 235 U , 233 U , 239 Pu

398 views • 29 slides

antibodies that guarantee reproducible research Andrew Bradbury, Specifica Inc Why move towards

Getting to recombinant antibodies that guarantee reproducible research Andrew Bradbury, Specifica Inc Why move towards recombinant Abs? Many commercial reagent antibodies have problems Both polyclonals and monoclonals Monoclonals

582 views • 36 slides

Antigen Antibody Reactions The interactions between antigens and antibodies are known as

Antigen Antibody Reactions The interactions between antigens and antibodies are known as antigen antibody reactions . The reactions are highly specific, and an antigen reacts only with antibodies produced by itself or with closely

122 views • 8 slides

Preparing for the Deliberate Use of Biological Weapons: The Relevance of the Biological Weapons

Preparing for the Deliberate Use of Biological Weapons: The Relevance of the Biological Weapons Convention to Central Asian States Parties Regional Workshop for Central Asian States Parties to the BWC On Preparedness to Respond to the

698 views • 25 slides

Weapons and Combat Systems Division Dr Shane Canney Acting Chief Weapons and Combat Systems

UNCLASSIFIED Weapons and Combat Systems Division Dr Shane Canney Acting Chief Weapons and Combat Systems Division 1 UNCLASSIFIED Weapons and Combat Systems Division (WCSD) Vision: To be at the forefront of the application of science and

378 views • 37 slides

Mologic partnering wit ith the In Institut Pasteur de Dakar Home of the Mologic Centre for

Mologic partnering wit ith the In Institut Pasteur de Dakar Home of the Mologic Centre for Advanced Rapid Diagnostics (The CARD) Coronavirus getting up-close and personal, warts and all! Coronavirus Footprints, fingerprints and

459 views • 24 slides

Crisis: An Open Forum Webinar Series for Pharmacists May 21, 2020 American Pharmacists

American Pharmacists Association Addressing the COVID-19 Crisis: An Open Forum Webinar Series for Pharmacists May 21, 2020 American Pharmacists Association Michael D. Hogue, PharmD, FAPHA, FNAP Dean and Professor Loma Linda University

832 views • 32 slides

First Presentation of Early Data for Pembrolizumab (MK-3475), Mercks Investigational Anti-PD-1

NEWS RELEASE First Presentation of Early Data for Pembrolizumab (MK-3475), Mercks Investigational Anti-PD-1 Antibody, in Advanced Head and Neck Cancer at ASCO 2014 6/1/2014 Overall Response Rate of 20 Percent for Pembrolizumab as Single

407 views • 6 slides

Nephritis Brad H. Rovin, MD Professor of Medicine and Pathology Division of Nephrology The Ohio

New Treatment Options for Lupus Nephritis Brad H. Rovin, MD Professor of Medicine and Pathology Division of Nephrology The Ohio State University Wexner Medical Center 1 The Clinical Trial Landscape Has Been Bleak Drug Class Target

2.94k views • 32 slides

J a n u a r y 20 1 8 SAB Team & Technology Together for 15+ Years Technology Purchased

J a n u a r y 20 1 8 SAB Team & Technology Together for 15+ Years Technology Purchased by SAB Biotherapeutics originated at the Kirin Pharma, begins independent University of BioDak Acquires IP, operations Massachusetts Kyowa

1.36k views • 16 slides

immunoYeast & The Antibody Discovery Toolkit Specific Antibodies on DemandSo What? Now,

immunoYeast & The Antibody Discovery Toolkit Specific Antibodies on DemandSo What? Now, you can... Visualize protein localization and identify different cell types: Precipitate proteins to find interaction partners: Measure

1.14k views • 28 slides

Antibody Generation System Maturation, Selection and Production in CHO Cells iGEM Team Potsdam

Antibody Generation System Maturation, Selection and Production in CHO Cells iGEM Team Potsdam Bioware 2012 Antibodies - State of the Art Hybridoma Technique Phage Display Technique immunization, killing, selection of fragments cell fusion,

637 views • 29 slides

Production of Homogeneous ADCs with Combination Warheads and Bispecifics using an Open Cell Free

Production of Homogeneous ADCs with Combination Warheads and Bispecifics using an Open Cell Free System Aaron K. Sato VP, Research Sutro Biopharma, Inc. What do you do? Aaron works with proteins 2 Three Simple Concepts Sutro

699 views • 53 slides